Upgrade to SI Premium - Free Trial

Chemours (CC) PT Raised to $30 at Mizuho

May 6, 2026 7:01 AM
Mizuho analyst John Roberts raised the price target on Chemours (NYSE: CC) to $30.00 (from $25.00) while maintaining a Outperform rating.

Categories

Analyst PT Change